PL1670762T3 - Pirydyloacetyleny do zastosowania jako radioznaczniki i środki obrazujące - Google Patents

Pirydyloacetyleny do zastosowania jako radioznaczniki i środki obrazujące

Info

Publication number
PL1670762T3
PL1670762T3 PL04765586T PL04765586T PL1670762T3 PL 1670762 T3 PL1670762 T3 PL 1670762T3 PL 04765586 T PL04765586 T PL 04765586T PL 04765586 T PL04765586 T PL 04765586T PL 1670762 T3 PL1670762 T3 PL 1670762T3
Authority
PL
Poland
Prior art keywords
pyridylacetylenes
radiotracers
imaging agents
imaging
agents
Prior art date
Application number
PL04765586T
Other languages
English (en)
Inventor
Fabrizio Gasparini
Yves Auberson
Lea Kessler
Simon Mensah Ametamey
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PL1670762T3 publication Critical patent/PL1670762T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/53Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL04765586T 2003-09-26 2004-09-24 Pirydyloacetyleny do zastosowania jako radioznaczniki i środki obrazujące PL1670762T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0322612.3A GB0322612D0 (en) 2003-09-26 2003-09-26 Organic compounds
PCT/EP2004/010743 WO2005030723A1 (en) 2003-09-26 2004-09-24 Pyridylacetylenes for use as radiotracers and imaging agents
EP04765586A EP1670762B1 (en) 2003-09-26 2004-09-24 Pyridylacetylenes for use as radiotracers and imaging agents

Publications (1)

Publication Number Publication Date
PL1670762T3 true PL1670762T3 (pl) 2013-05-31

Family

ID=29286926

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04765586T PL1670762T3 (pl) 2003-09-26 2004-09-24 Pirydyloacetyleny do zastosowania jako radioznaczniki i środki obrazujące

Country Status (13)

Country Link
US (2) US8674110B2 (pl)
EP (1) EP1670762B1 (pl)
JP (1) JP4965255B2 (pl)
CN (1) CN100430380C (pl)
AU (2) AU2004275971B2 (pl)
BR (1) BRPI0414732A (pl)
CA (1) CA2539469C (pl)
ES (1) ES2400713T3 (pl)
GB (1) GB0322612D0 (pl)
MX (1) MXPA06003424A (pl)
PL (1) PL1670762T3 (pl)
PT (1) PT1670762E (pl)
WO (1) WO2005030723A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0525068D0 (en) 2005-12-08 2006-01-18 Novartis Ag Organic compounds
US8349852B2 (en) 2009-01-13 2013-01-08 Novartis Ag Quinazolinone derivatives useful as vanilloid antagonists
JP2013518085A (ja) 2010-02-01 2013-05-20 ノバルティス アーゲー CRF−1受容体アンタゴニストとしてのピラゾロ[5,1b]オキサゾール誘導体
AR080056A1 (es) 2010-02-01 2012-03-07 Novartis Ag Derivados de ciclohexil-amida como antagonistas de los receptores de crf
JP5748777B2 (ja) 2010-02-02 2015-07-15 ノバルティス アーゲー Crf受容体アンタゴニストとしてのシクロヘキシルアミド誘導体
ES2492694T3 (es) * 2010-07-09 2014-09-10 Recordati Ireland Limited Nuevos compuestos espiroheterocíclicos como antagonistas de mGlu5
AR086554A1 (es) 2011-05-27 2014-01-08 Novartis Ag Derivados de la piperidina 3-espirociclica como agonistas de receptores de la ghrelina
AU2013255458A1 (en) 2012-05-03 2014-10-09 Novartis Ag L-malate salt of 2, 7 - diaza - spiro [4.5 ] dec- 7 - yle derivatives and crystalline forms thereof as ghrelin receptor agonists

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6843979B2 (en) 1999-04-26 2005-01-18 Emory University 4-haloethenylphenyl tropane:serotonin transporter imaging agents
EP1048302A3 (en) 1999-04-30 2002-07-17 Pfizer Products Inc. Radiotracers for in vivo study of acetylcholinesterase and Alzheimer's disease
AU5613900A (en) * 1999-06-30 2001-01-31 Sun Microsystems, Inc. Customizing web content based on network conditions
EP1214303A1 (en) 1999-08-31 2002-06-19 Merck & Co., Inc. Heterocyclic compounds and methods of use thereof
GB0103045D0 (en) * 2001-02-07 2001-03-21 Novartis Ag Organic Compounds
JP4070431B2 (ja) 2001-07-10 2008-04-02 ジーイー・ヘルスケア・リミテッド モノアミン再取込み部位のマッピング用ヨウ素付加神経プローブ
EP1556142A4 (en) * 2002-10-24 2006-11-08 Merck & Co Inc ALKYNE DERIVATIVES AS MARKERS FOR METABOTROPIC GLUTAMATE RECEPTOR BINDING

Also Published As

Publication number Publication date
AU2004275971A1 (en) 2005-04-07
US20090010838A1 (en) 2009-01-08
ES2400713T3 (es) 2013-04-11
US8674110B2 (en) 2014-03-18
WO2005030723A1 (en) 2005-04-07
GB0322612D0 (en) 2003-10-29
AU2008261192B2 (en) 2011-08-04
EP1670762A1 (en) 2006-06-21
JP4965255B2 (ja) 2012-07-04
CN100430380C (zh) 2008-11-05
CA2539469C (en) 2012-06-19
AU2008261192A1 (en) 2009-01-22
CA2539469A1 (en) 2005-04-07
JP2007506698A (ja) 2007-03-22
BRPI0414732A (pt) 2006-11-21
CN1856468A (zh) 2006-11-01
PT1670762E (pt) 2013-02-07
AU2004275971B2 (en) 2008-10-02
EP1670762B1 (en) 2012-12-05
US20140142318A1 (en) 2014-05-22
MXPA06003424A (es) 2006-06-20

Similar Documents

Publication Publication Date Title
EP1638612A4 (en) COX-2-MADE DISPLAY AGENTS
PL1670762T3 (pl) Pirydyloacetyleny do zastosowania jako radioznaczniki i środki obrazujące
GB0300805D0 (en) Compounds and their use
GB0300804D0 (en) Compounds and their use
GB0301143D0 (en) Compounds and their use
GB0317133D0 (en) Compounds and their use
GB0322658D0 (en) Compounds and their use
GB0316112D0 (en) Compounds and their use
GB0302933D0 (en) Compounds and their use
GB0323470D0 (en) Compounds and their use
GB0323000D0 (en) Compounds and their use
GB0324581D0 (en) Compounds and their use
GB0322011D0 (en) Compounds and their use
GB0321442D0 (en) Compounds and their use
GB0321301D0 (en) Compounds and their use
GB0320064D0 (en) Compounds and their use
GB0320062D0 (en) Compounds and their use
GB0317283D0 (en) Compounds and their use
GB0317281D0 (en) Compounds and their use
GB0317279D0 (en) Compounds and their use
GB0317278D0 (en) Compounds and their use
GB0324877D0 (en) Compounds and their use
GB0316205D0 (en) Compounds and their use
GB0316204D0 (en) Compounds and their use
GB0316203D0 (en) Compounds and their use